| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―26 |
Mechanism-informed identification of FDA-approved topoisomerase inhibitors disrupting SARS-CoV-2 nucleocapsid-RNA interactions |
Da-Wei Zhang, Xiao-Shuang Xu, Lei Xu, Liangxu Xie, Yimin Li, Shan Chang |
| 2 |
[GO] |
2025―Aug―21 |
Selective six spectrophotometric methods for determination of remdesivir and moxifloxacin hydrochloride for COVID-19 treatment with overlapping spectra: a comprehensive evaluation of greenness, blueness, and whiteness |
Eman A. Madbouly, Abdalla A. El-Shanawani, Sobhy M. El-Adl, Ahmed S. Abdelkhalek |
| 3 |
[GO] |
2025―Jul―10 |
Sustainable analysis of COVID-19 Co-packaged paxlovid: exploring advanced sampling techniques and multivariate processing tools |
Shymaa S. Soliman, Nisreen F Abo- Talib, Mohamed R. Elghobashy, Mona A. Abdel Rahman |
| 4 |
[GO] |
2025―May―02 |
Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma |
Sobhy M. El-Adl, Abdalla A. El-Shanawani, Eman A. Madbouly, Ahmed S. Abdelkhalek |
| 5 |
[GO] |
2025―Jan―09 |
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma |
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees |
| 6 |
[GO] |
2024―Nov―14 |
Bio-inspired one-pot synthesis of luminescent silver nanoparticles and its significant utility as a fluorescence nano sensor for analysis of two adjunctive COVID-19 drugs |
Yasmeen E. Mostafa, Fawzi Elsebaei, Mohammed El-Sayed Metwally |
| 7 |
[GO] |
2024―Oct―03 |
SMILES-based QSAR virtual screening to identify potential therapeutics for COVID-19 by targeting 3CLpro and RdRp viral proteins |
Faezeh Bazzi-Allahri, Fereshteh Shiri, Shahin Ahmadi, Alla P. Toropova, Andrey A. Toropov |
| 8 |
[GO] |
2024―May―11 |
Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches |
Muhammad Suleman, Abduh Murshed, Kashif Imran, Abbas Khan, Zafar Ali, Norah A. Albekairi, et al. (+3) Dong-Qing Wei, Hadi M. Yassine, Sergio Crovella |
| 9 |
[GO] |
2024―Apr―05 |
Green chemometric-assisted UV-spectrophotometric methods for the determination of favipiravir, cefixime and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in pharmaceutical form and spiked human plasma |
Eman A. Madbouly, Abdalla A. El-Shanawani, Sobhy M. El-adl, Ahmed S. Abdelkhalek |
| 10 |
[GO] |
2024―Mar―07 |
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof |
Sara I. Aboras, Ahmed A. Megahed, Fawzy El-Yazbi, Hadir M. Maher |
| 11 |
[GO] |
2023―Dec―07 |
Development and validation of chemometric-assisted spectrophotometric models for efficient quantitation of a binary mixture of supportive treatments in COVID-19 in the presence of its toxic impurities: a comparative study for eco-friendly assessment |
Heidi R. Abd El-Hadi, Maya S. Eissa, Hala E. Zaazaa, Basma M. Eltanany |
| 12 |
[GO] |
2023―Nov―24 |
Homogeneous liquid-liquid microextraction coupled with HPLC/DAD for determination of nirmatrelvir and ritonavir as COVID-19 combination therapy in human plasma |
Inas A. Abdallah, Sherin F. Hammad, Alaa Bedair, Fotouh R. Mansour |
| 13 |
[GO] |
2023―Nov―20 |
Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligands |
Eman Hassan Elsayed, Dhuha Al-Wahaib, Ali El-Dissouky Ali, Beshir A. Abd-El-Nabey, Hemmat A. Elbadawy |
| 14 |
[GO] |
2023―Oct―09 |
Green wastewater treatment of repurposed COVID-19 therapy (levofloxacin) using synthesized magnetite pectin nanoparticles, comparison with mesoporous silica nanoparticles |
Christine M. El-Maraghy, Sarah S. Saleh, Mervat S. Ibrahim, Omnia A. El-Naem |
| 15 |
[GO] |
2023―Sep―21 |
Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma |
Mohamed S. Imam, Ahmed H. Abdelazim, Sherif Ramzy, Ahmed A. Almrasy, Mohammed Gamal, Afnan S. Batubara |
| 16 |
[GO] |
2023―Sep―21 |
HPLC/UV approach method for the first simultaneous estimation of molnupiravir and ertapenem as a binary mixture in human plasma and dosage form as a regimen for COVID-19 treatments |
Khaled K. Afify, Ramadan Ali, Mohammad A. El-Dosoky, Mohamed wafaa I. Nassar |
| 17 |
[GO] |
2023―Aug―05 |
Development of green micellar HPLC-DAD method for simultaneous determination of some sulbactam combinations used in COVID-19 regimen |
Gamal H. Ragab, Hanaa M. Saleh, Nermeen M. Abdulla, Eman A. Bahgat |
| 18 |
[GO] |
2023―Jun―17 |
Synthesis, antimicrobial and antioxidant activity of triazole, pyrazole containing thiazole derivatives and molecular docking studies on COVID-19 |
Raghavender Matta, Jalapathi Pochampally, Bala Narsimha Dhoddi, Shankar Bhookya, Sampath Bitla, Anjini Gayatri Akkiraju |
| 19 |
[GO] |
2023―Jun―16 |
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation |
Afnan S. Batubara, Ahmed H. Abdelazim, Ahmed A. Almrasy, Mohammed Gamal, Sherif Ramzy |
| 20 |
[GO] |
2023―Mar―22 |
Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test |
Ahmed R. Mohamed, Ebrahim Abolmagd, Israa M. Nour, Mohamed Badrawy, Mohamed A. Hasan |
| 21 |
[GO] |
2023―Mar―14 |
Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approaches |
Mohammed E. A. Hammouda, Amal A. El-Masry, Saadia M. El-Ashry, Dalia R. El-Wasseef |
| 22 |
[GO] |
2022―Nov―02 |
Spectroscopic details on the molecular structure of pyrimidine-2-thiones heterocyclic compounds: computational and antiviral activity against the main protease enzyme of SARS-CoV-2 |
Doaa S. El Sayed, El-Sayed M. Abdelrehim |
| 23 |
[GO] |
2022―Oct―03 |
Eco-friendly resolution of spectrally overlapping signals of a combined triple-action over-the-counter pharmaceutical formulation for symptomatic management of COVID-19 pandemic: application to content uniformity testing |
Hoda M. Marzouk, Engy A. Ibrahim, Maha A. Hegazy, Samah S. Saad |
| 24 |
[GO] |
2022―Sep―27 |
Simultaneous analysis of two drugs used as supportive treatment for COVID-19: comparative statistical studies and analytical ecological appraisal |
Hany Ibrahim, Omar M El-Abassy, Hisham Ezzat Abdellatef, Hassan A. M. Hendawy, Heba M El-Sayed |
| 25 |
[GO] |
2021―Feb―02 |
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning |
Marcos V. S. Santana, Floriano P. Silva-Jr |
